Report Detail

Other Global Implantable Cardioverter-Defibrillators (ICD) Market Insights, Forecast to 2025

  • RnM2349729
  • |
  • 12 June, 2019
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Other

An implantable cardioverter defibrillator is a device that monitors a person's heart rate post its implantation in patients with heart failure. The device continuously monitors your heartbeat and sends electrical pulses to repair a normal heart rhythm when necessary. Implantable cardioverter defibrillator (ICD) or automated implantable cardioverter defibrillators can save patients from arrhythmias by regulating the irregular heartbeats. The device is used in treating sudden cardiac arrest caused due to cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia.
The global Implantable Cardioverter-Defibrillators (ICD) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Implantable Cardioverter-Defibrillators (ICD) market based on company, product type, end user and key regions.

This report studies the global market size of Implantable Cardioverter-Defibrillators (ICD) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Implantable Cardioverter-Defibrillators (ICD) in these regions.
This research report categorizes the global Implantable Cardioverter-Defibrillators (ICD) market by top players/brands, region, type and end user. This report also studies the global Implantable Cardioverter-Defibrillators (ICD) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ZOLL Medical Corporation (US)
Boston Scientific Corporation (US)
BIOTRONIK SE & Co. KG (Germany)
Medtronic PLC (Ireland)
St. Jude Medical, Inc. (US)
Koninklijke Philips N.V. (Netherlands)
Medtronic Plc
PHILIPS HEALTHCARE
Sorin Group
Nihon Kohden Corporation

Market size by Product
Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Market size by End User
ASCs
Hospital
Clinic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Implantable Cardioverter-Defibrillators (ICD) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Implantable Cardioverter-Defibrillators (ICD) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Implantable Cardioverter-Defibrillators (ICD) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Implantable Cardioverter-Defibrillators (ICD) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Implantable Cardioverter-Defibrillators (ICD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Implantable Cardioverter-Defibrillators (ICD) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Implantable Cardioverter-Defibrillators (ICD) Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Implantable Cardioverter-Defibrillators (ICD) Market Size Growth Rate by Product
      • 1.4.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
      • 1.4.3 Transvenous Implantable Cardioverter-Defibrillator (T-ICDs)
      • 1.4.4 Cardiac Resynchronization Therapy Defibrillator (CRT-D)
    • 1.5 Market by End User
      • 1.5.1 Global Implantable Cardioverter-Defibrillators (ICD) Market Size Growth Rate by End User
      • 1.5.2 ASCs
      • 1.5.3 Hospital
      • 1.5.4 Clinic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Implantable Cardioverter-Defibrillators (ICD) Market Size
      • 2.1.1 Global Implantable Cardioverter-Defibrillators (ICD) Revenue 2014-2025
      • 2.1.2 Global Implantable Cardioverter-Defibrillators (ICD) Sales 2014-2025
    • 2.2 Implantable Cardioverter-Defibrillators (ICD) Growth Rate by Regions
      • 2.2.1 Global Implantable Cardioverter-Defibrillators (ICD) Sales by Regions
      • 2.2.2 Global Implantable Cardioverter-Defibrillators (ICD) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Implantable Cardioverter-Defibrillators (ICD) Sales by Manufacturers
      • 3.1.1 Implantable Cardioverter-Defibrillators (ICD) Sales by Manufacturers
      • 3.1.2 Implantable Cardioverter-Defibrillators (ICD) Sales Market Share by Manufacturers
      • 3.1.3 Global Implantable Cardioverter-Defibrillators (ICD) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Implantable Cardioverter-Defibrillators (ICD) Revenue by Manufacturers
      • 3.2.1 Implantable Cardioverter-Defibrillators (ICD) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Implantable Cardioverter-Defibrillators (ICD) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Implantable Cardioverter-Defibrillators (ICD) Price by Manufacturers
    • 3.4 Implantable Cardioverter-Defibrillators (ICD) Manufacturing Base Distribution, Product Types
      • 3.4.1 Implantable Cardioverter-Defibrillators (ICD) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Implantable Cardioverter-Defibrillators (ICD) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Implantable Cardioverter-Defibrillators (ICD) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Implantable Cardioverter-Defibrillators (ICD) Sales by Product
    • 4.2 Global Implantable Cardioverter-Defibrillators (ICD) Revenue by Product
    • 4.3 Implantable Cardioverter-Defibrillators (ICD) Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Implantable Cardioverter-Defibrillators (ICD) Breakdown Data by End User

    6 North America

    • 6.1 North America Implantable Cardioverter-Defibrillators (ICD) by Countries
      • 6.1.1 North America Implantable Cardioverter-Defibrillators (ICD) Sales by Countries
      • 6.1.2 North America Implantable Cardioverter-Defibrillators (ICD) Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Implantable Cardioverter-Defibrillators (ICD) by Product
    • 6.3 North America Implantable Cardioverter-Defibrillators (ICD) by End User

    7 Europe

    • 7.1 Europe Implantable Cardioverter-Defibrillators (ICD) by Countries
      • 7.1.1 Europe Implantable Cardioverter-Defibrillators (ICD) Sales by Countries
      • 7.1.2 Europe Implantable Cardioverter-Defibrillators (ICD) Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Implantable Cardioverter-Defibrillators (ICD) by Product
    • 7.3 Europe Implantable Cardioverter-Defibrillators (ICD) by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) by Countries
      • 8.1.1 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Sales by Countries
      • 8.1.2 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) by Product
    • 8.3 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) by End User

    9 Central & South America

    • 9.1 Central & South America Implantable Cardioverter-Defibrillators (ICD) by Countries
      • 9.1.1 Central & South America Implantable Cardioverter-Defibrillators (ICD) Sales by Countries
      • 9.1.2 Central & South America Implantable Cardioverter-Defibrillators (ICD) Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Implantable Cardioverter-Defibrillators (ICD) by Product
    • 9.3 Central & South America Implantable Cardioverter-Defibrillators (ICD) by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Implantable Cardioverter-Defibrillators (ICD) by Countries
      • 10.1.1 Middle East and Africa Implantable Cardioverter-Defibrillators (ICD) Sales by Countries
      • 10.1.2 Middle East and Africa Implantable Cardioverter-Defibrillators (ICD) Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Implantable Cardioverter-Defibrillators (ICD) by Product
    • 10.3 Middle East and Africa Implantable Cardioverter-Defibrillators (ICD) by End User

    11 Company Profiles

    • 11.1 ZOLL Medical Corporation (US)
      • 11.1.1 ZOLL Medical Corporation (US) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.1.5 ZOLL Medical Corporation (US) Recent Development
    • 11.2 Boston Scientific Corporation (US)
      • 11.2.1 Boston Scientific Corporation (US) Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.2.5 Boston Scientific Corporation (US) Recent Development
    • 11.3 BIOTRONIK SE & Co. KG (Germany)
      • 11.3.1 BIOTRONIK SE & Co. KG (Germany) Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.3.5 BIOTRONIK SE & Co. KG (Germany) Recent Development
    • 11.4 Medtronic PLC (Ireland)
      • 11.4.1 Medtronic PLC (Ireland) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.4.5 Medtronic PLC (Ireland) Recent Development
    • 11.5 St. Jude Medical, Inc. (US)
      • 11.5.1 St. Jude Medical, Inc. (US) Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 St. Jude Medical, Inc. (US) Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 St. Jude Medical, Inc. (US) Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.5.5 St. Jude Medical, Inc. (US) Recent Development
    • 11.6 Koninklijke Philips N.V. (Netherlands)
      • 11.6.1 Koninklijke Philips N.V. (Netherlands) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Koninklijke Philips N.V. (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Koninklijke Philips N.V. (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.6.5 Koninklijke Philips N.V. (Netherlands) Recent Development
    • 11.7 Medtronic Plc
      • 11.7.1 Medtronic Plc Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Medtronic Plc Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.7.5 Medtronic Plc Recent Development
    • 11.8 PHILIPS HEALTHCARE
      • 11.8.1 PHILIPS HEALTHCARE Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 PHILIPS HEALTHCARE Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.8.5 PHILIPS HEALTHCARE Recent Development
    • 11.9 Sorin Group
      • 11.9.1 Sorin Group Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Sorin Group Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Sorin Group Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.9.5 Sorin Group Recent Development
    • 11.10 Nihon Kohden Corporation
      • 11.10.1 Nihon Kohden Corporation Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Nihon Kohden Corporation Implantable Cardioverter-Defibrillators (ICD) Products Offered
      • 11.10.5 Nihon Kohden Corporation Recent Development

    12 Future Forecast

    • 12.1 Implantable Cardioverter-Defibrillators (ICD) Market Forecast by Regions
      • 12.1.1 Global Implantable Cardioverter-Defibrillators (ICD) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Implantable Cardioverter-Defibrillators (ICD) Revenue Forecast by Regions 2019-2025
    • 12.2 Implantable Cardioverter-Defibrillators (ICD) Market Forecast by Product
      • 12.2.1 Global Implantable Cardioverter-Defibrillators (ICD) Sales Forecast by Product 2019-2025
      • 12.2.2 Global Implantable Cardioverter-Defibrillators (ICD) Revenue Forecast by Product 2019-2025
    • 12.3 Implantable Cardioverter-Defibrillators (ICD) Market Forecast by End User
    • 12.4 North America Implantable Cardioverter-Defibrillators (ICD) Forecast
    • 12.5 Europe Implantable Cardioverter-Defibrillators (ICD) Forecast
    • 12.6 Asia Pacific Implantable Cardioverter-Defibrillators (ICD) Forecast
    • 12.7 Central & South America Implantable Cardioverter-Defibrillators (ICD) Forecast
    • 12.8 Middle East and Africa Implantable Cardioverter-Defibrillators (ICD) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Implantable Cardioverter-Defibrillators (ICD) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Implantable Cardioverter-Defibrillators (ICD) . Industry analysis & Market Report on Implantable Cardioverter-Defibrillators (ICD) is a syndicated market report, published as Global Implantable Cardioverter-Defibrillators (ICD) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Implantable Cardioverter-Defibrillators (ICD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,910.20
      5,865.30
      7,820.40
      4,571.70
      6,857.55
      9,143.40
      753,424.00
      1,130,136.00
      1,506,848.00
      408,954.00
      613,431.00
      817,908.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report